Biosimilar Development solution center

1. Do Changes Signal The End Of Biosimilar Regulatory Redundancy? 4/23/2026

   First came excitement over the looming patent cliff. Then, FDA and EMA took big swings at what many have called redundant work. Combined, they make a more attractive environment for biosimilar developers.

2. ADC Development Grows More Complex — SPR Insights Bring Clarity 4/14/2026

   Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

3. New Research: Co-Expression Could Make Plant-Based Systems Viable 4/2/2026

   By co-expressing Protein A with the protein of interest, the work proposes to reduce the abundant cost of chromatography resins with a one-pot purification approach.

4. Biopharma Supply, Reimagined: Regional, Resilient Manufacturing 4/1/2026

   Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

5. Can Collaboration Close Biopharma's Talent Gap For Good? 3/17/2026

   Biopharma innovation is accelerating, but workforce shortages threaten progress. See how strengthening collaboration is essential to developing the skills needed for emerging therapies.

6. If Collaboration Fuels Biopharma Innovation, Why Can't We Connect More? 3/17/2026

   Breakthroughs thrive when biopharma teams work across silos, yet collaboration remains surprisingly difficult. Explore the barriers and why they persist. What will it take to move beyond them?

7. New MIT Consortium Links Innovation With Real-World Biomanufacturing 3/6/2026

   In one area, the Initiative for New Manufacturing is exploring whether microfactories, championed by the EV industry, can help biopharma iterate facility design faster.

8. Soil Testing: From Filtration To Fertilizer To Food 2/25/2026

   Soil analysis offers a clear view of the factors that influence land productivity while helping identify contaminants that could threaten safety. Understand the indicators to support sustainability decisions.

9. If Sustainability Is A Priority, Why Is Progress So Slow? 2/10/2026

   Sustainability is now central to biopharma strategy. New data reveals why commitments aren’t translating into action, and the roadblocks leaders must address to turn environmental ambition into change.

10. New ISPE Framework Targets Uncertainty In Pharma's AI Deployment 1/29/2026

    International Society for Pharmaceutical Engineering members developed the guide to offer a risk-based framework for evaluating, implementing, and maintaining AI systems.